| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |